Research Article
Concomitant Sjögren’s Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis
Table 4
Liver-related adverse events at the end of observation.
| ||||||||||||||||||||||||||||||||
HCC, hepatocellular carcinoma; SS, Sjögren’s syndrome; and PBC, primary biliary cholangitis. |